• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不完全的细胞去定植可能解释了牛输尿管移植物的高失败率。

Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts.

作者信息

Spark J I, Yeluri S, Derham C, Wong Y T, Leitch D

机构信息

Leeds Vascular Institute, Leeds General Infirmary, Leeds, UK.

出版信息

Br J Surg. 2008 May;95(5):582-5. doi: 10.1002/bjs.6052.

DOI:10.1002/bjs.6052
PMID:18344206
Abstract

BACKGROUND

The aim was to assess the results of a decellularized bovine ureter graft (SynerGraft) for complex venous access.

METHODS

Bovine ureter conduits were implanted in patients with a failed fistula or access graft in whom native vessels were unsuitable as conduits. Graft histories were obtained from all patients who had undergone this procedure at one institution. Failed grafts were explanted and subjected to histological examination. A sample of fresh bovine ureter was immunostained for galactose (alpha1 --> 3) galactose (alpha-Gal).

RESULTS

Nine patients with a median age of 46 (range 25-70) years underwent complex venous access surgery between August 2004 and November 2006 using a SynerGraft. Graft types included loop superficial femoral artery to stump of long saphenous vein (four patients), loop brachial artery to vein (two), brachial artery to axillary vein (two) and left axillary artery to innominate vein (one). Three grafts developed aneurysmal dilatation and two thrombosed. Histological assessment of the explanted bovine ureters revealed acute and chronic transmural inflammation. Immunostaining of fresh bovine ureter suggested residual cells and the xenoantigen alpha-Gal.

CONCLUSION

Graft failure with aneurysmal dilatation and thrombosis in complex arteriovenous conduits using bovine ureter may be due to residual xenoantigens.

摘要

背景

目的是评估脱细胞牛输尿管移植物(SynerGraft)用于复杂静脉通路的效果。

方法

将牛输尿管导管植入内瘘或血管移植物失败且自身血管不适合作为导管的患者体内。从在一家机构接受该手术的所有患者获取移植物病史。取出失败的移植物并进行组织学检查。对新鲜牛输尿管样本进行半乳糖(α1→3)半乳糖(α-Gal)免疫染色。

结果

2004年8月至2006年11月期间,9例中位年龄为46岁(范围25 - 70岁)的患者使用SynerGraft进行了复杂静脉通路手术。移植物类型包括股浅动脉袢至大隐静脉残端(4例患者)、肱动脉袢至静脉(2例)、肱动脉至腋静脉(2例)以及左腋动脉至无名静脉(1例)。3个移植物发生动脉瘤样扩张,2个形成血栓。对取出的牛输尿管进行组织学评估显示有急性和慢性透壁性炎症。新鲜牛输尿管的免疫染色提示存在残留细胞和异种抗原α-Gal。

结论

使用牛输尿管的复杂动静脉导管移植物出现伴有动脉瘤样扩张和血栓形成的移植物失败可能归因于残留的异种抗原。

相似文献

1
Incomplete cellular depopulation may explain the high failure rate of bovine ureteric grafts.不完全的细胞去定植可能解释了牛输尿管移植物的高失败率。
Br J Surg. 2008 May;95(5):582-5. doi: 10.1002/bjs.6052.
2
Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model.在犬类模型中用作动静脉移植物的去细胞牛输尿管的细胞重塑。
J Am Coll Surg. 2004 May;198(5):778-83. doi: 10.1016/j.jamcollsurg.2004.01.020.
3
Randomized clinical trial comparing decellularized bovine ureter with expanded polytetrafluoroethylene for vascular access.比较脱细胞牛输尿管与膨体聚四氟乙烯用于血管通路的随机临床试验。
Br J Surg. 2009 Jan;96(1):34-9. doi: 10.1002/bjs.6434.
4
Depopulated bovine ureteric xenograft for complex haemodialysis vascular access.用于复杂血液透析血管通路的去细胞牛输尿管异种移植物
Eur J Vasc Endovasc Surg. 2006 Feb;31(2):181-6. doi: 10.1016/j.ejvs.2005.07.006. Epub 2005 Aug 29.
5
Massive aneurysmal dilatation of a depopulated ureteric hemodialysis xenograft.去细胞输尿管血液透析异种移植物的巨大动脉瘤样扩张。
Hemodial Int. 2009 Jan;13(1):3-5. doi: 10.1111/j.1542-4758.2009.00349.x.
6
Bovine ureter graft for haemodialysis access surgery.用于血液透析通路手术的牛输尿管移植物
Nephrol Dial Transplant. 2006 Aug;21(8):2290-1. doi: 10.1093/ndt/gfl164. Epub 2006 Apr 21.
7
Secondary patency of thrombosed prosthetic vascular access grafts with aggressive surveillance, monitoring and endovascular management.通过积极监测、监控和血管内管理实现血栓形成的人工血管通路移植物的二期通畅。
Eur J Vasc Endovasc Surg. 2008 Sep;36(3):356-65. doi: 10.1016/j.ejvs.2008.05.007. Epub 2008 Jul 7.
8
Use of the femoral artery route for placement of temporary catheters for emergency haemodialysis when all usual central venous access sites are exhausted.当所有常用的中心静脉通路部位都已用尽时,使用股动脉途径放置用于紧急血液透析的临时导管。
Nephrol Dial Transplant. 2009 Mar;24(3):913-8. doi: 10.1093/ndt/gfn582. Epub 2008 Oct 24.
9
The pathology of depopulated bovine ureter xenografts utilized for vascular access in haemodialysis patients.用于血液透析患者血管通路的去细胞牛输尿管异种移植物的病理学
Histopathology. 2009 Aug;55(2):154-60. doi: 10.1111/j.1365-2559.2009.03360.x.
10
Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access.继发性动静脉瘘:将人工血管动静脉移植物转换为自体透析通路。
Semin Dial. 2008 Sep-Oct;21(5):474-82. doi: 10.1111/j.1525-139X.2008.00459.x. Epub 2008 Jun 20.

引用本文的文献

1
Quercetin-Loaded Nanoparticle-Modified Decellularized Tissue-Engineered Vascular Graft Regulates Macrophage Polarization and Promotes In Vivo Graft Remodeling.载槲皮素纳米颗粒修饰的去细胞组织工程血管移植物调节巨噬细胞极化并促进体内移植物重塑。
Int J Nanomedicine. 2025 Mar 5;20:2761-2778. doi: 10.2147/IJN.S505674. eCollection 2025.
2
Mechanical characterization of porcine ureter for the evaluation of tissue-engineering applications.用于评估组织工程应用的猪输尿管的力学特性
Front Bioeng Biotechnol. 2024 Jun 17;12:1412136. doi: 10.3389/fbioe.2024.1412136. eCollection 2024.
3
Personalized tissue-engineered arteries as vascular graft transplants: A safety study in sheep.
个性化组织工程动脉作为血管移植移植物:在绵羊身上的安全性研究。
Regen Ther. 2022 Sep 7;21:331-341. doi: 10.1016/j.reth.2022.08.005. eCollection 2022 Dec.
4
Decellularized blood vessel development: Current state-of-the-art and future directions.去细胞血管的发展:当前的技术水平与未来方向。
Front Bioeng Biotechnol. 2022 Aug 8;10:951644. doi: 10.3389/fbioe.2022.951644. eCollection 2022.
5
Bioengineered tissue solutions for repair, correction and reconstruction in cardiovascular surgery.用于心血管手术修复、矫正和重建的生物工程组织解决方案。
J Thorac Dis. 2018 Jul;10(Suppl 20):S2390-S2411. doi: 10.21037/jtd.2018.04.27.
6
In Vivo Performance of Decellularized Vascular Grafts: A Review Article.脱细胞血管移植物的体内性能:一篇综述文章。
Int J Mol Sci. 2018 Jul 19;19(7):2101. doi: 10.3390/ijms19072101.
7
Stem Cell Sources and Graft Material for Vascular Tissue Engineering.用于血管组织工程的干细胞来源与移植材料
Stem Cell Rev Rep. 2018 Oct;14(5):642-667. doi: 10.1007/s12015-018-9825-x.
8
The Rapidly Evolving Concept of Whole Heart Engineering.全心工程的快速发展概念
Stem Cells Int. 2017;2017:8920940. doi: 10.1155/2017/8920940. Epub 2017 Nov 9.
9
Vascular scaffolds with enhanced antioxidant activity inhibit graft calcification.具有增强抗氧化活性的血管支架可抑制移植物钙化。
Biomaterials. 2017 Nov;144:166-175. doi: 10.1016/j.biomaterials.2017.08.014. Epub 2017 Aug 14.
10
Natural Scaffolds for Regenerative Medicine: Direct Determination of Detergents Entrapped in Decellularized Heart Valves.再生医学用天然支架:脱细胞心脏瓣膜中包裹的去污剂的直接测定。
Biomed Res Int. 2017;2017:9274135. doi: 10.1155/2017/9274135. Epub 2017 Jun 6.